Evidence map›Paper›PMID 41131566›Full record

ArticleNutrition journal2025

Feasibility of using Simple Diet Self-Assessment Tool (SDSAT) to explore patterns of dietary intake for patients undergoing chemotherapy.

Wen-Jie Zhu, Min Yang, Bao-Hua Zou, Hui-Min Qu, Hong-Fan Yu, Qian-Tong Dong, Xi Zhang, Jia-Xin Huang, Xiao-Dong Chen, Zhen-Guang Du and 13 more

Abstract read
In one paragraph

Article in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Wen-Jie Zhu *Comprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Min Yang *Comprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Bao-Hua Zou *Comprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Hui-Min QuDepartment of Medicine, Gesi (Hebei) Medical Research Institute, Langfang, Hebei, China.
Hong-Fan YuState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, No.1, Medical College Road, Yuzhong District, 400016, Chongqing, China.
Qian-Tong DongDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Xi ZhangComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Jia-Xin HuangComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Xiao-Dong ChenDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Zhen-Guang DuDepartment of Oncology III, Liaoning People's Hospital, Shenyang, Liaoning, China.
Ning LiComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Cong ZhaoComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Le TianComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Jin-Feng LiuComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Meng TangComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Sheng-Ling QinComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Rong QinComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Rui SunComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Lei YuComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Jiang LiOffice for Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xian ShenDepartment of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China. 13968888872@163.com.
Qiuling ShiState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, No.1, Medical College Road, Yuzhong District, 400016, Chongqing, China. qshi@cqmu.edu.cn.
Ming-Hua CongComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China. congmh@cicams.ac.cn.

Funding

Wu Jieping Medical Foundation 320.6750.2021-02-22
6 · The paper itself

Abstract

backgroundChemotherapy is often accompanied by impaired dietary intake, which is linked to poor clinical outcomes if not effectively addressed. Predicting dietary changes can facilitate early nutritional support, but the dynamic patterns and interindividual variability in dietary intake during chemotherapy remain unclear. Our aim was thus to evaluate the feasibility of using the Simple Diet Self-Assessment Tool (SDSAT) to establish dietary intake patterns in patients undergoing chemotherapy.

methodsThis is an ongoing, prospective cohort study. Patients receiving chemotherapy from the Cancer Hospital, Chinese Academy of Medical Sciences were enrolled. Diet was assessed using the SDSAT once before the treatment and at least three times during one chemotherapy cycle. We applied a group-based trajectory model to identify trajectories of dietary intake. The 24-hour dietary recall (24HR) was used to verify the validity of energy and protein intake estimated by SDSAT; compliance with SDSAT was also assessed.

resultsFive trajectory groups were identified for food intake based on 217 chemotherapy cycles by 56 patients. The compliance rate accounted for 81.11% for 4 cumulative responses per cycle. The agreement between the SDSAT score and the dietary energy and protein intake estimated from 24HR was high (κ: 0.888–1.0, P < 0.001). Groups 1 and 2 had significantly lower dietary energy/protein intake than Groups 4 and 5 (P < 0.001) but with distinct dietary patterns. Group 4 was the most common dietary trajectory (35.10%). Furthermore, Groups 1, 2, and 3 had significantly weaker handgrip strength (OR: 1.10, 95% CI: 1.01–1.19, P = 0.031) compared with Groups 4 and 5.

conclusionsSDSAT can be used to establish dietary trajectories during one chemotherapy cycle. Longitudinal analysis highlights the interindividual differences in dietary intake patterns among patients receiving chemotherapy and may help to inform proactive and individually tailored nutritional interventions. TRAIL REGISTRATION: Chictr.org.cn Identifier: ChiCTR2100047535 (Date: 2021-06-20) https://www.chictr.org.cn/indexEN.html .

Indexed as

Antineoplastic AgentsDietNeoplasmsNutrition AssessmentSelf-AssessmentAdultAgedDietary ProteinsEnergy IntakeFeasibility StudiesFemaleHumansMaleMiddle AgedPatient ComplianceProspective StudiesAntineoplastic AgentsDietary ProteinsCancerChemotherapyDietary patternsMalnutritionTrajectory

Identifiers

PMID41131566
PMCPMC12548285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.